Stereotactic Body Radiotherapy for Primary Renal Cell Carcinoma: Outcomes, Safety, and Practice Guidelines
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)
Lancet Oncol 2024 Jan 01;25(1)e18-e28, S Siva, AV Louie, R Kotecha, MN Barber, M Ali, Z Zhang, M Guckenberger, MS Kim, M Scorsetti, AC Tree, BJ Slotman, A Sahgal, SS LoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.